Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
epilepsy
3
×
life sciences
national blog main
blackstone group
boston
boston blog main
boston top stories
clinical trials
david goldstein
depression
essential tremor
kiran reddy
major depressive disorder
national top stories
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
steven petrou
abide therapeutics
aligos therapeutics
allergan
amylin pharmaceuticals
antisense oligonucleotide
baker brothers life sciences
ben cravatt
benzodiazepine
benzodiazepines
biogen
biotech ipos
blackstone life sciences
blepharitis
botox
bristol-myers squibb
cavion
cephalgia
chronic hepatitis b virus
columbia university
demodex blepharitis
What
medicines
3
×
drugs
praxis
precision
research
abide
aims
appointed
backed
biotechs
cause
central
ceo
chief
cns
developing
diseases
disorder
emerged
epilepsy
executive
finney
genes
genetic
ipos
kept
kevin
leads
links
marcio
mutations
nervous
neuro
neurological
new
officer
operating
prep
president
quiet
Language
unset
Current search:
epilepsy
×
medicines
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
